ZTS Downgraded by Jefferies -- Price Target Lowered to $83.00

gurufocus.com · 2026-10-20

Zoetis Inc. Analyst Rating Update On October 16, 2023, Jefferies downgraded Zoetis (ZTS) to Hold from Buy. The new price target has been set at $83.00, down

TickrTrends take: Jefferies' downgrade and reduced price target of $83 represent a significant reassessment of Zoetis that contrasts with TickrTrends' current undervalued classification for the Healthcare sector company. The gap between the analyst's new $83 target and the market's current pricing creates a key metric for valuation-focused investors to monitor, as it suggests potential tension between institutional analyst sentiment and quantitative valuation models. Investors relying on fundamental valuation analysis should track whether the downgrade reflects concerns about earnings sustainability or whether it presents a divergence worth examining further against the company's actual business performance.

Read the full story at gurufocus.com →